Jacob Hughes
Stock Analyst at Wells Fargo
(1.33)
# 3,518
Out of 4,959 analysts
27
Total ratings
50%
Success rate
-1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $30.50 | +44.26% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $24.49 | +120.50% | 1 | Sep 6, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $1.27 | +923.62% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $17.61 | +218.09% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $9.23 | +311.70% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Equal-Weight | $12 → $11 | $18.46 | -40.41% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $7.49 | +126.97% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $30.50
Upside: +44.26%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $24.49
Upside: +120.50%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $1.27
Upside: +923.62%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $17.61
Upside: +218.09%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $9.23
Upside: +311.70%
Teva Pharmaceutical Industries
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $18.46
Upside: -40.41%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $7.49
Upside: +126.97%